⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockCanadaNYSE

BHC

Bausch Health Companies Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

6.44USD

-0.0500 (-0.77%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BHC.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 6.44
P/E—
Dvd Ind Yld0.0%
P/B—
P/S0.2
Curr EV/T12M EBITDA10.9
Mkt Cap (USD)2.4B
Curr EV (USD)22.3B
2)

Per Share Data

EPS T12M-2.96
DPS—
Bk Val Per Sh-4.74
Rev/Sh28.70
Cash/Sh4.88
Curr Shares Out374.0M
FCF/Sh3.78
3)

Cash Flow Analysis

P/CF1.3
Curr P/FCF1.7
CF/NI-1.6
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales16.6%
Eff Interest Rate7.6%
4)

Growth Potential

Dil EPS 1Y Gr423.1%
Cap 1Y Gr-0.4%
BPS 1Y Gr57.5%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr6.7%
FCF 1Y Gr-20.4%
Assets 1Y Gr-0.6%
5)

Profitability

EBITDA2.1B
EBIT0.9B
Operating Margin8.1%
Pretax Margin-6.7%
Net Margin-10.1%
ROA-4.2%
ROE86.6%
ROC—
Asset Turnover0.42
6)

Structure

Current Ratio1.44
Quick Ratio0.90
Debt/Assets83.7%
Debt/Com Eq-1171.1%
Net Debt/EBITDA9.20
Tot Debt/Capital109.3%
Gross Margin56.0%
EBIT/Int Exp0.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.